China's vaccine specialist CanSino Biologics Inc has won a patent approval from Beijing for its COVID19 vaccine candidate Ad5nCOV, state media reported, citing documents from the country's intellectual property regulator. from Top Business News- News18.com Read The Rest:timesnownews...
No comments: